Customers will also share data from studies using the technologies including an effort to investigate protein biomarkers for ...

to stay at the forefront of genomics technology. In recent quarters, Illumina has focused on expanding its sequencing ...

Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting: San Diego Monday, November 4, 2024, 17:0 ...

Illumina's margin expansion and a coming revenue recovery should help the stock multiples re-rate toward life science ...

Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. Stay up-to ...

On November 7, Illumina will showcase PIPseq V, a single-cell analysis solution currently on the market from Fluent BioSciences, an Illumina company.

Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences: ...

Unlike Illumina's NovaSeq X devices — which are as large as a Xerox copier and designed for in-depth sequencing — the ... development based on technology in the NovaSeq X platform that has ...

San Diego-based Illumina, a global leader in genomic sequencing technology, unveiled its latest machines that could make analyzing genetics cheaper, more efficient and more accessible to researchers.

with Illumina's proven and highly scalable sequencing technology, the partnership aims to deliver innovative solutions to researchers and breeders in the As Illumina, Inc. (NASDAQ: ILMN), a global ...

A collaborative study by researchers from Baylor College of Medicine and Illumina has showcased the exceptional capabilities of the DRAGEN (Dynamic Read Analysis for GENomics) platform in ...

Illumina’s strategic initiatives include the launch of the MiSeq i100 Series, a new benchtop sequencer aimed at accelerating genomic innovation. The company has also announced plans to expand its ...